Zilia Secures Bridge Financing with Linearis Ventures

Zilia Inc. has closed a bridge financing round with participation from Linearis Ventures and existing investors to advance its oculomics platform.

Zilia Inc. has successfully closed a bridge financing round, which included participation from new investors such as Linearis Ventures, alongside reinvestment from current shareholders. This funding milestone was announced in a press release and is aimed at scaling the commercialization of Zilia's flagship technology, the Zilia Ocular™, a non-invasive device that measures biomarkers in the eye.

The Zilia Ocular™ combines imaging, spectroscopy, and artificial intelligence to provide real-time insights into ocular and systemic health. The company is advancing toward FDA clearance for its ocular oximetry technology, complementing an initial FDA 510(k) clearance received in 2023 for its Zilia Ocular FC™ retinal camera.

Linearis Ventures will also serve as a strategic advisor on AI development, leveraging its expertise to support Zilia's growth and innovation in ophthalmic biomarkers. This collaboration is part of Zilia's broader strategy to expand into cardiology and neurology, supported by a major institutional raise planned for later this year.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like AI Funding Brief.

Also, consider following us on social media:

Subscribe to Daily AI Brief

Daily report covering major AI developments and industry news, with both top stories and complete market updates

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more